Skip to main content

Updated from 4:07 p.m. EDT

Stocks in New York briefly flirted with positivity Wednesday afternoon but sold off into the close after an increase in crude prices and disappointing July retail sales news earlier in the day dealt a double blow to investor sentiment.


Dow Jones Industrial Average

lost 109.51 points, or 0.9%, to 11,532.96, and the

S&P 500

dropped 3.77 points, or 0.3%, to 1,285.82. The


shed 1.99 points, or 0.1%, to 2,428.62.

Crude-oil inventories for the week ended Aug. 8 decreased by 400,000 barrels, and gasoline supplies dropped by 6.4 million barrels. The price of crude oil jumped $3.27 to $116.28 a barrel following the announcement. Gold rose $16.90 to close at $831.50 an ounce.

On the economic data front, the Census Bureau reported that retail sales decreased 0.1% in July, a result that fell short of economists' projections for a flat reading. Barring automobiles, retail sales increased 0.4%, less than the expectation for a 0.5% increase.

The Bureau of Labor Statistics' import price index rose 1.7% in July. Excluding oil, the price of imported goods increased 0.9%. Export prices, excluding agricultural products, rose 0.8% in July, a smaller increase than 0.9% in June.

Peter Cardillo, chief market economist at Avalon Partners, said that the retail sales data weren't that negative, especially discounting automobile sales. He also said that the U.S. consumer is struggling, but he doesn't foresee an actual drop in spending.

"I think the market is basically ... pulling back from the strong rally, the dollar-oil rally that we had the past week or so," he said. He said that as the market decouples from the trend of a rising dollar and declining oil prices, it may try to retest its July lows.

The sales data "was reported as close to consensus as you can get," said Haseeb Ahmed, U.S. economist for JPMorgan Economics. "Things are slowing down on the consumer-spending front as the rebates are fading, but they're not collapsing." He said that the government's stimulus package did help prop up the consumer during the second quarter. The recent drop in gasoline prices will help, but will not be enough to offset the waning effect of the rebate checks in coming months, he said.

The Census Bureau also announced Wednesday that business inventories rose 0.7% in June, a larger-than-expected jump and a larger one than the 0.4% increase in May.

TheStreet Recommends

Traders will also be focusing on the behavior of numerous financial-services stocks, as well as mortgage giants

Fannie Mae



Freddie Mac


, following Tuesday's expiration of a government regulation banning so-called naked short-selling of their stocks. Fannie fell 4.1% to $7.69, while Freddie added 3.4% to $5.55.

On the companies side, semiconductor firm


(NVDA) - Get NVIDIA Corporation Report

said it swung to a quarterly loss because of flawed chips and a failure to anticipate the impact of a new graphics chip from rival

Advanced Micro Devices

(AMD) - Get Advanced Micro Devices, Inc. Report

. However, the announcement of a share buyback gave the stock a boost. Nvidia shares ended up 11% at $12.26.

Another piece of discouraging news in the semiconductor sphere came from

Applied Materials

(AMAT) - Get Applied Materials, Inc. Report

, which said its profit declined 65% for the third quarter owing to the economic slowdown. Shares nonetheless climbed 4.7% to $19.33 after the company said upcoming quarters would yield improved performance.

In other earnings news, farm-equipment maker


(DE) - Get Deere & Company Report

reported third-quarter earnings that rose year over year but fell short of analyst expectations. Shares fell 3.2% to $67.10. Dow component and fellow equipment manufacturer


(CAT) - Get Caterpillar Inc. Report

was trading down on Deere's results, down 2.8% to $69.83. Department-store operator


(M) - Get Macy's Inc Report

announced a decline in second-quarter profit and lowered its full-year outlook. Shares climbed 1.9% to $20.66.

On the corporate merger scene, drug store operator

CVS Caremark

(CVS) - Get CVS Health Corporation Report

said it would buy

Longs Drug Stores


for roughly $2.6 billion in an effort to expand its presence in the western U.S. CVS ended the day down 0.1% at $38.03, while Long Drug shot up 31% to $70.70.

Meanwhile, biotech firm



rejected a $43.7 billion buyout offer from Swiss drug developer, which already owns a majority of Genentech shares. The stock climbed 0.5% to $98.37.

In analyst actions, Citigroup initiated ratings coverage on homebuilders

Toll Brothers

(TOL) - Get Toll Brothers, Inc. Report


Pulte Homes

(PHM) - Get PulteGroup, Inc. Report





MDC Holdings

(MDC) - Get M.D.C. Holdings, Inc. Report



(LEN) - Get Lennar Corporation Class A Report




. Toll and Pulte garnered buy ratings, while the remainder received hold recommendations. The bullish take wasn't enough to lift the sector, as the

SPDR S&P Homebuilders

(XHB) - Get SPDR S&P Homebuilders ETF Report

, an exchange-traded fund that tracks the group, lost 1% to $18.54.

Elsewhere, Merrill Lynch downgraded both

Goldman Sachs

(GS) - Get Goldman Sachs Group, Inc. Report


Lehman Brothers


to underperform. Merrill also reduced its rating on

Morgan Stanley

(MS) - Get Morgan Stanley Report

to neutral from buy. Goldman lost 1.4% to $164.90, and Morgan Stanley gave up 5.5% to $40.15.

Away from stocks, U.S. Treasury prices were decreasing. The 10-year note was down 11/32 in price to yield 3.94%, and the 30-year was shedding 16/32 to yield 4.56%. The dollar was trouncing the pound, but weakening vs. the yen and the euro.

Overseas exchanges, including the FTSE in London, the DAX in Frankfurt, the Nikkei in Tokyo and the Hang Seng in Hong Kong, were mostly trading lower.

Get your daily dose of Jim Cramer and all the stocks in his head. Sign up for the free Daily Booyah! newsletter by clicking here.